Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops

Código QR

Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops

Eiichi UchioDepartment of Ophthalmology, Fukuoka University School of Medicine, Fukuoka, JapanAbstract: Olopatadine hydrochloride exerts a wide range of pharmacological actions such as histamine H1 receptor antagonist action, chemical mediator suppressive action, and eosinophil infiltration suppress...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Eiichi Uchio
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/9f248f53c110442eba26dee9edf280ba
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model
por: Torkildsen G, et al.
Publicado: (2015)

Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis
por: McLaurin E, et al.
Publicado: (2017)

Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis
por: Patricia B Williams, et al.
Publicado: (2010)

Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies
por: Arthur B Epstein, et al.
Publicado: (2009)

Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%
por: Jack V Greiner, et al.
Publicado: (2011)

Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
por: Mizoguchi T, et al.
Publicado: (2017)

Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review
por: Makuloluwa AK, et al.
Publicado: (2018)

Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis
por: Jeremy B Wingard, et al.
Publicado: (2011)

Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%
por: Bergmann MT, et al.
Publicado: (2014)

Corneal sensitivity after topical bromfenac sodium eye-drop instillation
por: Yanai K, et al.
Publicado: (2013)

Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis
por: Chigbu DI, et al.
Publicado: (2015)

Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.2% ophthalmic solution evaluated by patient preference
por: McCabe CF, et al.
Publicado: (2012)

Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies
por: Meier E, et al.
Publicado: (2017)

Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy
por: Gomes PJ, et al.
Publicado: (2013)

Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections
por: Darlene Miller
Publicado: (2008)

Comparison of novel lipid-based eye drops with aqueous eye drops for dry eye: a multicenter, randomized controlled trial
por: Simmons PA, et al.
Publicado: (2015)

Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model
por: Awara A, et al.
Publicado: (2020)

Efficacy of retinol palmitate eye drops for dry eye in rabbits with lacrimal gland resection
por: Odaka A, et al.
Publicado: (2012)

Virological and epidemiological analysis of coxsackievirus A24 variant epidemic of acute hemorrhagic conjunctivitis in Okinawa, Japan, in 2011
por: Harada K, et al.
Publicado: (2015)

Proficiency of eye drop instillation in postoperative cataract patients in Ghana
por: Liu Y, et al.
Publicado: (2013)

Lipid-containing osmoprotective eye drops in contact lens wearers
por: Aslan Bayhan S, et al.
Publicado: (2014)

Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis
por: Daoud Al-Badriyeh, et al.
Publicado: (2010)

The eye drop chart: a pilot study for improving administration of and compliance with topical treatments in glaucoma patients
por: McVeigh KA, et al.
Publicado: (2015)

Systane&reg; lubricant eye drops in the management of ocular dryness
por: Benelli U
Publicado: (2011)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
por: Inoue K, et al.
Publicado: (2015)

Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis
por: Timothy L Comstock, et al.
Publicado: (2010)

Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis
por: Cervantes LJ, et al.
Publicado: (2011)

Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials
por: Ciolino JB, et al.
Publicado: (2015)

Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose
por: Cohen S, et al.
Publicado: (2013)

Safety of cetirizine ophthalmic solution 0.24% for the treatment of allergic conjunctivitis in adult and pediatric subjects
por: Malhotra RP, et al.
Publicado: (2019)

Fluoroquinolone antibacterial eye drops: effects on normal human corneal epithelium, stroma, and endothelium
por: Ryou Watanabe, et al.
Publicado: (2010)

Evaluation of the efficacy and safety of a new device for eye drops instillation in patients with glaucoma
por: Junqueira DM, et al.
Publicado: (2015)

Cytotoxicity of prostaglandin analog eye drops preserved with benzalkonium chloride in multiple corneoconjunctival cell lines
por: Masahiko Ayaki, et al.
Publicado: (2010)

A randomized clinical evaluation of the safety of Systane&reg; Lubricant Eye Drops for the relief of dry eye symptoms following LASIK refractive surgery
por: Daniel Durrie, et al.
Publicado: (2008)

Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infections
por: Silverstein BE, et al.
Publicado: (2012)

The effects of lubricant eye drops on visual function as measured by the Inter-blink interval Visual Acuity Decay test
por: Gail Torkildsen
Publicado: (2009)

Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops
por: Rosin LM, et al.
Publicado: (2013)

Antiadenoviral effects of N-chlorotaurine in vitro confirmed by quantitative polymerase chain reaction methods
por: Eiichi Uchio, et al.
Publicado: (2010)

Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profile
por: Haas W, et al.
Publicado: (2011)

Dexamethasone/Netilmicin Eye Drops and Eye Gel for the Treatment of Ocular Inflammation After Micro-Incisional Vitreoretinal Surgery
por: Rapisarda A, et al.
Publicado: (2020)